Jihad S. Inshasi
Dubai, DU, United Arab Emirates
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.
Journal: Journal of neurology
Published: November 01, 2025
Long-term Real-world Safety and Efficacy of Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis: The UAE Experience.
Journal: Multiple sclerosis and related disorders
Published: September 01, 2025
The real-world effectiveness and safety of off-label rituximab in a large cohort of Middle Eastern multiple sclerosis patients.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: June 19, 2025
Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS Guidelines.
Journal: CNS drugs
Published: April 21, 2025
Role of Immune Reconstitution Therapy with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in Older Patients.
Journal: Neurology and therapy
Published: April 08, 2025
Comparative effectiveness of natalizumab and anti-CD20 monoclonal antibodies in relapsing-remitting multiple sclerosis: a real-world propensity-score matched study.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: December 20, 2024
MOGAD and NMOSD: insights on patients' radiological and laboratory findings from a single UAE center.
Journal: Frontiers in neurology
Published: August 14, 2024
Safety and effectiveness of disease-modifying therapies after switching from natalizumab.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 26, 2024
Cost-effectiveness of ofatumumab for the treatment of relapsing forms of multiple sclerosis in the United Arab Emirates.
Journal: Therapeutic advances in neurological disorders
Published: July 16, 2024
Practical Recommendations from the Gulf Region on the Therapeutic Use of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis: Impact of the Latest Real-World Evidence on Clinical Practice.
Journal: Neurology and therapy
Published: June 18, 2024
Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based study.
Journal: Multiple sclerosis and related disorders
Published: May 19, 2024
Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study.
Journal: Neurology
Published: March 06, 2024
Last Updated: 09/26/2026